Palliative Care Research Training Grant

项目总结/摘要 华盛顿大学（UW）的这份T32续签申请侧重于一个关键的和未充分研究的 研究领域-心脏、肺和血液疾病的姑息治疗研究。人口老龄化， 慢性病管理的进步结合起来，产生了对改善姑息治疗的巨大需求， 对不同疾病的护理研究。心脏、肺和血液疾病是导致死亡的主要原因 和残疾在美国和代表领域的姑息治疗研究落后于癌症。 该应用程序与其他T32程序不同，侧重于为患者提供姑息治疗研究的培训 患有心脏、肺部和血液疾病。因为姑息治疗中的健康差异已经有了很好的记录， 这一创新培训方案还侧重于了解和消除这些差距。这项建议 利用跨多个学校（医学，护理， 公共卫生，药学和社会工作）在华盛顿大学，和多个部门内的华盛顿大学学院 药J. Randall Curtis博士，创始项目主任，是姑息治疗研究的全国领导者 并获得了K24奖的指导从NHLBI整整10年。他也是主任， UW Cambia姑息治疗卓越中心（PCCE）支持此T32。随着这次续约 应用程序，柯蒂斯博士是增加两个优秀的新项目主任，都R 01资助的领导人在姑息治疗 护理研究：坎比亚PCCE研究培训主任Erin Kross博士和Abby Rosenberg博士， Cambia PCCE儿科主任。我们提出了一个严格的研究培训计划建立在四个 核心原则，以准备新的研究人员独立的职业生涯：1）学员必须掌握一套明确的 成为独立但合作的研究者所需的核心内容和研究技能; 2） 结构化的研究指导和学术职业发展对于留住科学培训生至关重要 3）研究项目必须针对每个受训者量身定制，并设计成培训工具， 促进早期学术生产力和成功; 4）姑息治疗研究的培训应提供真实的 提供跨学科互动的机会，促进团队科学。不断改进我们 计划，我们将评估我们的方法的有效性，培训和指导使用定义明确的指标， 并根据需要调整我们的方法我们要求与我们最初的4个博士后培训名额相同的4个博士后培训名额 T32这一应用代表了推进心脏姑息治疗研究的重要机会， 肺和血液疾病，以解决2016年NHLBI战略愿景中的关键紧迫问题，并 为未来创造一支研究队伍。

PROJECT SUMMARY/ABSTRACT This T32 renewal application from the University of Washington (UW) focuses on a critical and understudied area of research – palliative care research for heart, lung, and blood diseases. Our aging population and advances in chronic disease management have combined to create an enormous need for improved palliative care research across diverse diseases. Heart, lung, and blood diseases encompass leading causes of death and disability in the US and represent areas where palliative care research lags behind compared to cancer. This application differs from other T32 programs by focusing on training in palliative care research for patients with heart, lung, and blood diseases. Because health disparities in palliative care have been well documented, this innovative training program also focuses on understanding and eliminating these disparities. This proposal capitalizes on the exceptional faculty and academic environment across multiple schools (Medicine, Nursing, Public Health, Pharmacy, and Social Work) at the UW, and multiple departments within the UW School of Medicine. Dr. J. Randall Curtis, the founding program director, is a national leader in palliative care research and was a recipient of a K24 Award for mentoring from NHLBI for the full 10 years. He is also the Director of the UW Cambia Palliative Care Center of Excellence (PCCE) which supports this T32. With this renewal application, Dr. Curtis is adding two outstanding new program directors, both R01-funded leaders in palliative care research: Dr. Erin Kross, Director of Research Training for the Cambia PCCE, and Dr. Abby Rosenberg, Director of Pediatrics for the Cambia PCCE. We propose a rigorous research training program built on four core principles to prepare new researchers for independent careers: 1) Trainees must master a defined set of core content and research skills necessary to become independent yet collaborative investigators; 2) Structured research mentoring and academic career development are critical to retaining trainees in science careers; 3) Research projects must be tailored to each trainee and designed to be training vehicles that facilitate early academic productivity and success; 4) Training in palliative care research should provide real opportunities for interdisciplinary interactions and promote team-science. To continuously improve our program, we will assess the effectiveness of our methods for training and mentoring using well-defined metrics, and adjust our methods as necessary. We are requesting the same 4 post-doctoral training slots as our initial T32. This application represents an important opportunity to advance palliative care research concerning heart, lung, and blood diseases, to address key compelling questions in the 2016 NHLBI Strategic Vision, and to create a research workforce for the future.